http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. There is no strong evidence to back the use of cannabis extract in the treatment of Multiple Sclerosis (MS), concludes a review of the available evidence on the first licensed preparation, published in the December issue of Drug and Therapeutics Bulletin (DTB). http://medicalxpress.com/news/2012-12-strong-evidence-cannabis-multiple-sclerosis.html Neuroscience Wed, 12 Dec 2012 18:30:05 EST news274554384 An extract from the plant Cannabis sativa (trade name Sativex) was approved in May 2011 for patients suffering from moderate to severe spastic paralysis and muscle spasms due to multiple sclerosis (MS). In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether the new drug, which is used as a mouth spray, offers an added benefit over the optimized standard therapy. However, no such added benefit can be inferred from the dossier, as the drug manufacturer deviated from the specifications of the Federal Joint Committee (G-BA) and chose a different comparator therapy. http://medicalxpress.com/news/2012-09-added-benefit-cannabis-sativa-spasticity.html Medications Mon, 17 Sep 2012 10:31:52 EST news267096705 A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant itself could soon be making their way to pharmacy shelves, according to drug companies, small biotech firms and university scientists. http://medicalxpress.com/news/2012-01-pot-based-prescription-drug-fda.html Medications Mon, 23 Jan 2012 04:05:13 EST news246513892